Latest Biotechnology, Pharmaceutical and Healthcare News from EPM Magazine

09:04 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "EPM Magazine" found in our extensive news archives from over 250 global news sources.

More Information about EPM Magazine on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about EPM Magazine for you to read. Along with our medical data and news we also list EPM Magazine Clinical Trials, which are updated daily. BioPortfolio also has a large database of EPM Magazine Companies for you to search.

Showing News Articles 1–25 of 699 from EPM Magazine

Monday 24th September 2018

BeiGene selects GE Healthcare to help manufacture cancer antibody

GE Healthcare has teamed up with biotechnology company BeiGene to help manufacture its cancer monoclonal antibodies (mAbs).

Friday 21st September 2018

EPM talks quality assurance with Formpipe Life Science

EPM speaks to Ben Saxton, Europe head of sales at Formpipe Life Science about why data preservation is important if firms are to ensure quality and compliance.

Thursday 20th September 2018

New non-antibiotic drug for TB developed by UK scientists

The first non-antibiotic drug to treat tuberculosis (TB) in animals has been developed by scientists at the University of Manchester.

Wednesday 19th September 2018

Recipharm gains EU Hub's approval to submit serialisation data

Contract development and manufacturing organisation (CDMO) Recipharm has received approval by the European Medicines Verification Organisation (EMVO) to submit serialisation data to the European Hub.

Monday 17th September 2018

PHE fails to publish vaccine trial results

A decision by Public Health England to not publish the results of three clinical trials into vaccines for children has been criticised by scientist

Thursday 13th September 2018

FDA accepts supplemental biologics licence application for Praluent

The US Food and Drug Administration (FDA) has accepted a supplemental biologics licence application (sBLA) for Praluent (alirocumab) injection as a potential treatment to reduce major adverse cardiovascular events.

SGS reveals investment into North American biopharmaceutical testing capabilities

Biopharmaceutical analytical and bioanalytical contract solutions provider, SGS, has revealed it is investing more than $1.7 million to expand its North American biopharmaceutical testing capabilities in Illinois.

Collaboration forms for development of targeted immunotherapies to treat cancer

Morphogenesis — Florida-based immunotherapy company — and the Cell and Gene Therapy Group at Karolinska Institutet (KI) in Sweden have announced a collaboration for the development of targeted immunotherapies to treat cancer.

Pall Biotech & Aetos Biologics partner to offer biosimilar manufacturing solutions

Filtration, separation and purification specialist, Pall, has announced a strategic partnership between its Pall Biotech business using and Aetos Biologics — a biosimilar cell line development company.

GSK signs up to recruitment system to drive diversity in student and graduate talent

It has been revealed that GlaxoSmithKline (GSK) — a global science-led healthcare company — has signed up to the Contextual Recruitment System (CRS) run by diversity recruitment specialist, Rare, to gain a more diverse range of talent.

Wednesday 12th September 2018

Gerresheimer and Sensile presenting drug delivery products at CPhI for first time this year

Gerresheimer is set to present its position as an original equipment manufacturer (OEM) for drug delivery platforms at CPhI Worldwide later this year.

Deal between Texas Medical Center & Department for International Trade to boost UK’s life sciences

A landmark ‘BioBridge’ collaboration deal between the Department for International Trade (DIT) and the Texas Medical Center (TMC) is anticipated to give the UK’s life sciences industry a major boost.

Vineti and World Courier partner to extend reach of cell and gene therapies

Digital traceability and orchestration solution for cell and gene therapies, Vineti, and specialist logistics company, World Courier, have partnered to further extend the reach of cell and gene therapies worldwide.

Researchers gain better understanding of colon cancer that could help develop treatments

Researchers at the University of Luxembourg have discovered a molecular mechanism giving them a better understanding of how colon cancer develops and progresses, which could aid in the development of treatments to inhibit tumour growth.

Partnership forms to enhance potential to identify hit drug candidates

Provider of label-free drug discovery solutions, SAMDI Tech, has joined forces with a provider of products and services that accelerate research and drug development efforts, Charles River Laboratories, to maximise its clients’ opportunities

Tuesday 11th September 2018

Clinical collaboration announced for window of opportunity study into breast cancer

Biotechnology company, Oncolytics Biotech, has announced a clinical collaboration with an academic research group dedicated to clinical and translational research in breast cancer, SOLTI.

PCI Pharma Services acquires Sherpa Clinical Packaging

Global biopharmaceutical outsourcing services provider, PCI Pharma Services, has acquired California-based Sherpa Clinical Packaging — a provider of clinical trial supply services.

More disparity in KRAS mutations may mean varied drug development is needed, notes study

According to a new study, led by the University of Eastern Finland, there is much more variation in cancer-causing KRAS mutations than originally believed.

New training course for robotics and automation launched by EEF

EEF, the manufacturers’ organisation, has launched a new training course within the area of robotics and automation.

Monday 10th September 2018

FDA approved new dosage strength of maintenance treatment for opioid dependence

The US Food and Drug Administration (FDA) has approved new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence.

Two-year strategic collaboration forms focusing on CETSA method

A two-year strategic research collaboration and licence agreement has been formed between Karolinska Institute spin out, Pelago Bioscience, and Vertex Pharmaceuticals that will focus on the CETSA method.

RSP Systems closes Series B round with additional €3.85 million

Non-invasive diagnostics company, RSP Systems, has completed the second closing of its Series B funding round, bringing in an additional €3.85 million and increasing the total of the round to €10.35 million.

Inoviem Scientific & XoNovo enter service-based partnership

Inoviem Scientific, a contract research biotech, has entered into a service-based partnership with XoNovo, a preclinical-stage biopharmaceutical company that is developing a proprietary small molecule for the treatment of neurodegenerative diseases

Friday 7th September 2018

The top five tweets: From recycling to serialisation — what made EPM readers click through this week?

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics.

CYTOO and Pfizer join forces for Duchenne Muscular Dystrophy target discovery platform

Preclinical stage drug discovery company, CYTOO, and biopharmaceutical company, Pfizer, have announced a research collaboration with the aim of developing a target discovery platform for Duchenne Muscular Dystrophy (DMD).

Quick Search


News Quicklinks